All-cause procedural readmissions following transcatheter aortic valve replacement
Paige Newell(Brigham and Women's Hospital), Tsuyoshi Kaneko(Brigham and Women's Hospital), Ashraf A. Sabe(Brown University), Pinak Shah, Mehida Rojas-Alexandre(Brigham and Women's Hospital), Olena Cherkasky(Brigham and Women's Hospital), Hoda Javadikasgari(Brigham and Women's Hospital), Morgan Harloff(Brigham and Women's Hospital), Siobhan McGurk(Brigham and Women's Hospital), Sameer Hirji(Harvard University), Alexandra Malarczyk(Brigham and Women's Hospital)
Cited by 0
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Intramyocardial Transplantation of Autologous CD34 <sup>+</sup> Stem Cells for Intractable Angina
|Circulation|2007|557
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
|European Heart Journal|2018|377
Variable Accuracy of Wearable Heart Rate Monitors during Aerobic Exercise
|Medicine & Science in Sports & Exercise|2017|349